Barriers and Facilitators to OTC Hearing Aids Success
Launched by YU-HSIANG WU · Jul 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the experiences of people with mild-to-moderate hearing loss who choose between two different ways to get hearing aids: over-the-counter (OTC) hearing aids and traditional audiologist (AUD) pathways. The goal is to understand how these two approaches affect users' satisfaction and overall experiences. OTC hearing aids are designed to be more affordable and allow users to diagnose their hearing loss and fit the devices themselves, while the AUD pathway involves visiting a professional for a more personalized fitting and ongoing support.
To participate, you should be an adult aged 65 to 74 with mild-to-moderate hearing loss and no previous experience using hearing aids. Participants will be followed for 12 months after they start using their hearing aids, with check-ins at 1, 6, and 12 months to discuss how satisfied they are with their devices and any challenges they face. This study is currently not yet recruiting, but it aims to provide valuable insights into how different options for hearing aids can affect people's lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult-onset, perceived bilateral mild-to-moderate hearing loss
- • no previous hearing aid experience
- Exclusion Criteria:
- • Non-native speaker of English
About Yu Hsiang Wu
Yu-Hsiang Wu is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a strong focus on collaboration and scientific integrity, Yu-Hsiang Wu leads initiatives that explore cutting-edge therapies across various therapeutic areas. The organization emphasizes rigorous protocol design and adherence to regulatory standards, ensuring the highest quality data generation and participant safety. By fostering partnerships with healthcare professionals and research institutions, Yu-Hsiang Wu aims to contribute valuable insights to the medical community and enhance the development of new treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Nashville, Tennessee, United States
Nashville, Tennessee, United States
Patients applied
Trial Officials
Yu-Hsiang Wu, PhD
Principal Investigator
University of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported